GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Slc22a8 | decreases expression | EXP | | 6480464 | CTD | Methotrexate results in decreased expression of SLC22A8 protein | PMID:16925582 | Slc22a8 | increases uptake | EXP | | 6480464 | CTD | SLC22A8 protein results in increased uptake of Methotrexate | PMID:35019195 | Slc22a8 | multiple interactions | EXP | | 6480464 | CTD | Leucovorin inhibits the reaction [Methotrexate results in decreased expression of SLC22A8 protein]; Probenecid inhibits the reaction [SLC22A8 protein results in increased uptake of Methotrexate]; tranilast inhibits the reaction [SLC22A8 protein results in increased uptake of Methotrexate] | PMID:16925582 PMID:35019195 | Slc22a8 | affects transport | ISO | SLC22A8 (Homo sapiens) | 6480464 | CTD | SLC22A8 protein affects the transport of Methotrexate | PMID:11306713 | Slc22a8 | increases response to substance | ISO | SLC22A8 (Homo sapiens) | 6480464 | CTD | SLC22A8 protein results in increased susceptibility to Methotrexate | PMID:27377006 | Slc22a8 | increases uptake | ISO | SLC22A8 (Homo sapiens) | 6480464 | CTD | SLC22A8 protein results in increased uptake of Methotrexate | PMID:16098483 PMID:27377006 PMID:28890383 | Slc22a8 | multiple interactions | ISO | SLC22A8 (Homo sapiens) | 6480464 | CTD | resveratrol inhibits the reaction [SLC22A8 protein results in increased uptake of Methotrexate]; rhein metabolite inhibits the reaction [SLC22A8 protein results in increased uptake of Methotrexate] | PMID:27377006 PMID:28890383 | |
Go Back to source page | Continue to Ontology report |